Hungarian nuclear medicine supplier Medi-Radiopharma is launching an R&D investment to develop a pioneering manufacturing technology, the Hungarian Investment Promotion Agency (HIPA) reports. Supported by the HIPA, the EUR 6.56 million investment aims to introduce an industry-scale, automated technology to produce radiopharmaceuticals, that is faster, and more efficient and accurate than the currently dominant manual, […]